|
A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) Clinical research trials and A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes). A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) clinical trial. Human subjects often get the best healthcare available for their A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes) condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes)  A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes)
A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes)
For Condition: Diabetes Mellitus,Insulin Resistance
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) ,
Synopsis: The goal of this study is to aggressively treat insulin resistance and its clinical manifestations when they first appear in childhood, and to prevent the subsequent progression towards impaired glucose tolerance and type-2 diabetes. In the process of this clinical trial, we will learn more about the early manifestations of insulin resistance, its treatment, and its relationship to obesity and type-2 diabetes through parallel in-vivo and in-vitro studies.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 5 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: 1. Obese patients (wt > 95th percentile for age, for adults increased BMI > 27) greater than 5 years of age 2. And/or presence of complications of insulin resistance such as acanthosis nigricans, dyslipidemia, elevated blood pressure, hyperandrogenism 3. Siblings and parents of patients with insulin resistance. Siblings and parents will be included only in the case of documented insulin resistance in the index subject. Insulin resistance will be documented by OGTT and/or IVGTT. 4. Family history of type II diabetes. Exclusion Criteria: 1. Critically ill patients, patients will congestive heart failure, renal or liver insufficiency 2. Inability to give consent. 3. History of poor compliance with physician's recommendations
Total Enrollment: 300
Location and Contact Information:
Cornell University
New York City, New York, 10021
United States
Additional Information:
Study ID Numbers: NCRR-M01RR06020-0057;
Study Start Date:
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00015626
Other Diabetes Mellitus Studies:
1. Genetic Studies of Insulin and Diabetes
2. Lipoprotein Metabolism in Hypertensive African-Americans
3. Underlying abnormalities in fat and muscle leading to Lipodystrophy Syndrome
4. Epidemiology of Stress and the Metabolic Syndrome
5. Genetics of the Metabolic Syndrome in Japanese Americans
Related Studies:
Other Diabetes Mellitus Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes)
|
|
|
|
|
|
|
|
